Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 14, 2017; 23(2): 357-365
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.357
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.357
Table 1 Distribution of the number of documents published on liver abscess, by publication type and clinical research approach (2001-2015)
Year | Publication type | Document category (by clinical research approach) | ||||||||
Article | Review | Letter | Others | Total1 | Case reports | Clinical trial | Evaluation studies | Others | Total1 | |
2001 | 68 | 13 | 9 | - | 90 | 60 | - | - | - | 60 |
2002 | 60 | 8 | 8 | 1 | 77 | 48 | 1 | - | - | 49 |
2003 | 70 | 12 | 12 | - | 94 | 63 | 2 | 2 | 1 | 68 |
2004 | 67 | 16 | 4 | - | 87 | 43 | 1 | 1 | 1 | 46 |
2005 | 62 | 3 | 7 | - | 72 | 49 | 1 | - | - | 50 |
2006 | 67 | 6 | 13 | 1 | 87 | 55 | 1 | - | - | 56 |
2007 | 76 | 6 | 16 | - | 98 | 73 | - | 1 | - | 74 |
2008 | 53 | 4 | 9 | - | 66 | 37 | 1 | 2 | - | 40 |
2009 | 71 | 7 | 12 | - | 90 | 59 | 3 | - | - | 62 |
2010 | 60 | 9 | 7 | 1 | 77 | 56 | 1 | 1 | - | 58 |
2011 | 79 | 5 | 15 | - | 99 | 74 | - | 3 | 1 | 78 |
2012 | 71 | 8 | 7 | 1 | 87 | 63 | 2 | 1 | - | 66 |
2013 | 80 | 9 | 17 | - | 106 | 67 | 1 | - | - | 68 |
2014 | 77 | 12 | 11 | 2 | 102 | 64 | 2 | 1 | 1 | 68 |
2015 | 39 | 3 | 4 | - | 46 | 31 | - | - | 1 | 32 |
Total | 1000 | 121 | 151 | 6 | 1278 | 842 | 16 | 12 | 5 | 875 |
Table 2 Distribution of the top 15 countries that have led research on liver abscess, pyogenic liver abscess, and amebic liver abscess (2001-2015)
Liver abscess | Liver abscess, amebic | Liver abscess, pyogenic | Total | ||||
Country | n | Country | n | Country | n | Country | n |
United States | 165 | India | 69 | Taiwan | 71 | United States | 229 |
Japan | 107 | Mexico | 69 | United States | 39 | Taiwan | 185 |
Taiwan | 103 | United States | 29 | China | 29 | India | 145 |
South Korea | 81 | France | 21 | South Korea | 21 | Japan | 144 |
India | 67 | Germany | 21 | Japan | 19 | South Korea | 100 |
China | 53 | Japan | 18 | India | 13 | China | 84 |
Germany | 51 | United Kingdom | 16 | Spain | 11 | Mexico | 81 |
Spain | 48 | Taiwan | 12 | Italy | 8 | Germany | 77 |
France | 42 | Malaysia | 10 | Turkey | 7 | France | 68 |
United Kingdom | 35 | Brazil | 9 | United Kingdom | 6 | Spain | 63 |
Italy | 34 | Pakistan | 9 | Germany | 6 | United Kingdom | 57 |
Turkey | 31 | Bangladesh | 7 | Singapore | 6 | Italy | 49 |
Singapore | 21 | Italy | 7 | Australia | 5 | Turkey | 42 |
Canada | 16 | Thailand | 6 | France | 5 | Brazil | 28 |
Australia | 16 | Spain/Turkey | 5 | Brazil/Canada | 5 | Singapore | 27 |
Table 3 Distribution of the top 20 descriptors and topic qualifiers assigned to papers on liver abscess and type of liver abscess (2001-2015)
Liver abscess | Liver abscess, amebic | Liver abscess, pyogenic | |||||||||
Descriptor | n | Qualifier | n | Descriptor | n | Qualifier | n | Descriptor | n | Qualifier | n |
Liver abscess | 1278 | Complications | 560 | Liver abscess, amebic | 414 | Diagnosis | 181 | Liver abscess, pyogenic | 344 | Complications | 167 |
Humans | 1227 | Diagnosis | 555 | Humans | 352 | Parasitology | 172 | Humans | 341 | Microbiology | 158 |
Male | 845 | Microbiology | 537 | Male | 272 | Complications | 106 | Male | 266 | Diagnosis | 152 |
Female | 580 | Etiology | 495 | Entamoeba histolytica | 207 | Therapeutic use | 104 | Female | 185 | Etiology | 120 |
Middle aged | 549 | Pathology | 321 | Animals | 190 | Pathology | 102 | Middle aged | 173 | Isolation and purification | 95 |
Adult | 411 | Surgery | 309 | Adult | 146 | Drug therapy | 94 | Aged | 139 | Therapeutic use | 88 |
Aged | 391 | Therapeutic use | 307 | Middle aged | 141 | Immunology | 93 | Adult | 128 | Therapy | 87 |
Tomography, X-ray computed | 363 | Isolation and purification | 294 | Female | 127 | Isolation & purification | 91 | Klebsiella pneumoniae | 92 | Drug therapy | 66 |
Anti-bacterial agents | 227 | Drug therapy | 277 | Metronidazole | 76 | Therapy | 75 | Klebsiella infections | 91 | Surgery | 64 |
Drainage | 194 | Therapy | 274 | Cricetinae | 67 | Etiology | 72 | Anti-bacterial agents | 85 | Pathology | 64 |
Treatment outcome | 181 | Radiography | 248 | Diagnosis, differential | 62 | Genetics | 67 | Retrospective studies | 74 | Radiography | 56 |
Diagnosis, differential | 179 | Methods | 222 | Tomography, X-ray computed | 59 | Epidemiology | 62 | Tomography, X-ray computed | 71 | Methods | 56 |
Liver neoplasms | 173 | Adverse effects | 177 | Entamoebiasis | 52 | Metabolism | 59 | Aged, 80 and over | 69 | Epidemiology | 56 |
Klebsiella infections | 164 | Ultrasonography | 138 | Aged | 51 | Pathogenicity | 59 | Treatment outcome | 64 | Mortality | 35 |
Klebsiella pneumoniae | 163 | Administration and dosage | 97 | Liver | 48 | Methods | 58 | Drainage | 62 | Ultrasonography | 32 |
Liver | 142 | Genetics | 95 | Treatment outcome | 47 | Blood | 47 | Risk Factors | 49 | Genetics | 25 |
Retrospective studies | 133 | Epidemiology | 91 | Antibodies, protozoan | 45 | Radiography | 39 | Adolescent | 39 | Metabolism | 24 |
Animals | 131 | Pathogenicity | 68 | Dysentery, amebic | 44 | Surgery | 37 | Diagnosis, differential | 33 | Pathogenicity | 19 |
Aged, 80 and over | 118 | Classification | 67 | Antiprotozoal agents | 43 | Ultrasonography | 36 | Taiwan | 30 | Adverse effects | 19 |
Adolescent | 94 | Secondary | 65 | Drainage | 41 | Analysis | 35 | Prognosis | 30 | Administration and dosage | 16 |
Table 4 Topic clusters and descriptors integrated within each for papers on liver abscess (2001-2015)
Cluster 1 (13 items) | Cluster 2 (8 items) | Cluster 3 (8 items) | Cluster 4 (7 items) | Cluster 5 (6 items) | Cluster 6 (6 items) | Cluster 5 (5 items) | Cluster 6 (5 items) |
Antigens, bacterial | Bile duct neoplasms | Cholecystitis | Contrast media | Catheterization | Biopsy, needle | Anti-bacterial agents | Biopsy |
Bacterial capsules | Carcinoma, Hepatocellular | Colonoscopy | Cysts | Cholangio-pancreatography | Risk, assessment | Ceftriaxone | Laparoscopy |
Bacterial proteins | Catheter ablation | Echinococcosis, hepatic | Diagnosis, differential | Drainage | Severity of illness index | Gram-positive bacterial infections | Liver |
Community-acquired infections | Chemoembolization, Therapeutic | Fatal outcome | Hemangioma | Endosonography | Suction | Metronidazole | Liver cirrhosis |
Diabetes complications | Cholangiocarcinoma | Intestinal perforation | Image enhancement | Stents | Time factors | Sepsis | Necrosis |
Electrophoresis, gel, pulsed field | Focal nodular Hyperplasia | Splenic diseases | Liver diseases | Ultrasonography, Interventional | Treatment outcome | - | - |
Klebsiella infections | Hepatectomy | Tomography, X-ray computed | Sensitivity and specificity | - | - | - | - |
Klebsiella pneumoniae | Liver neoplasms | Ultrasonography | - | - | - | - | - |
Phenotype | - | - | - | - | - | - | - |
Polysaccharides, bacterial | - | - | - | - | - | - | - |
Serotyping | - | - | - | - | - | - | - |
Virulence | - | - | - | - | - | - | - |
Virulence factors | - | - | - | - | - | - | - |
- Citation: González-Alcaide G, Peris J, Ramos JM. Areas of research and clinical approaches to the study of liver abscess. World J Gastroenterol 2017; 23(2): 357-365
- URL: https://www.wjgnet.com/1007-9327/full/v23/i2/357.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i2.357